Literature DB >> 7002349

The role of platelets in acute vascular events.

L A Harker, J L Ritchie.   

Abstract

Platelets are postulated to have an important role in acute and chronic cardiovascular events. Clinical events may result during the sequence of platelet activation reactions of adhesion, aggregate formation, release of granular constituents, thromboxane A2 formation, microembolization and platelet vascular occlusion. For example, sudden death may occur in patients with increased platelet sensitivity to catecholamine stimulation, platelet aggregate formation and thromboxane A2 generation resulting in ischemic ventricular arrhythmia induced by small-vessel platelet microembolization and local thromboxane A2 vasoconstriction. Whereas angina might be manifest if the microemboli disaggregated and vasospasm were transient, myocardial infarction would follow extensive permanent occlusion of small vessels or localized narrowing by vasospasm and extension of platelet thrombus formation at the site of intimal thickening. Platelets may also have an important role in atherogenesis through the mediation of the platelet-derived growth factor in the proliferative smooth muscle cell intimal lesion. Direct experimental and indirect clinical studies support the concept that platelets are important in cardiovascular events, but the relationship to spasm and to other possibly even more important mechanisms is not clear. Acute myocardial infarction and mural thrombogenesis appear to have the greatest evidence of being platelet-related.

Entities:  

Mesh:

Year:  1980        PMID: 7002349

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

Review 1.  Platelet activation in acute myocardial infarction and the rationale for combination therapy.

Authors:  I Conde-Pozzi; N Kleiman
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

2.  Acetylsalicylic acid and autonomic modulation.

Authors:  R E De Meersman; A S Zion; J S Lieberman; J A Downey
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

Review 3.  Aspirin and exercise as a prophylaxis for heart disease. Is it safe?

Authors:  R E De Meersman
Journal:  Sports Med       Date:  1990-02       Impact factor: 11.136

4.  Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components.

Authors:  A Ugur Ural; M Ilker Yilmaz; Ferit Avcu; Atilla Yalcin
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

Review 5.  Profile of an ideal antianginal agent.

Authors:  E J Lazar; W H Frishman
Journal:  Drugs       Date:  1989       Impact factor: 9.546

6.  Platelet reactivity in patients with chronic kidney disease and hemodialysis.

Authors:  Philipp Mourikis; Carolin Helten; Lisa Dannenberg; Thomas Hohlfeld; Johannes Stegbauer; Tobias Petzold; Bodo Levkau; Tobias Zeus; Malte Kelm; Amin Polzin
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

7.  Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS.

Authors:  O Vesterqvist
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs.

Authors:  G H Rao; J G White
Journal:  Agents Actions       Date:  1985-07

Review 9.  Coagulative interventions during angiography.

Authors:  J J Bookstein; K M Moser; C Hougie
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

10.  Flow analysis of individual blood extracellular vesicles in acute coronary syndrome.

Authors:  Murad Vagida; Anush Arakelyan; Anna Lebedeva; Jean-Charles Grivel; Alexander Shpektor; Elena Vasilieva; Leonid Margolis
Journal:  Platelets       Date:  2016-09-05       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.